NKAIN4
gene geneOn this page
Also known as bA261N11.2FAM77A
Summary
NKAIN4 (sodium/potassium transporting ATPase interacting 4, HGNC:16191) is a protein-coding gene on chromosome 20q13.33, encoding Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 (Q8IVV8).
NKAIN4 is a member of a family of mammalian proteins (see NKAIN1; MIM 612871) with similarity to Drosophila Nkain and interacts with the beta subunit of Na,K-ATPase (ATP1B1; MIM 182330) (Gorokhova et al., 2007 [PubMed 17606467]).
Source: NCBI Gene 128414 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_152864
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16191 |
| Approved symbol | NKAIN4 |
| Name | sodium/potassium transporting ATPase interacting 4 |
| Location | 20q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA261N11.2, FAM77A |
| Ensembl gene | ENSG00000101198 |
| Ensembl biotype | protein_coding |
| OMIM | 612873 |
| Entrez | 128414 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000370307, ENST00000370313, ENST00000370316, ENST00000370317, ENST00000461738, ENST00000466885, ENST00000470246, ENST00000472670, ENST00000486495
RefSeq mRNA: 3 — MANE Select: NM_152864
NM_001363718, NM_001363747, NM_152864
CCDS: CCDS13514, CCDS86967, CCDS86968
Canonical transcript exons
ENST00000370316 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001837307 | 63254397 | 63254463 |
| ENSE00003466466 | 63242539 | 63242623 |
| ENSE00003469479 | 63247578 | 63247775 |
| ENSE00003493300 | 63249935 | 63250072 |
| ENSE00003569280 | 63248815 | 63248895 |
| ENSE00003597170 | 63240784 | 63241506 |
| ENSE00003612624 | 63244024 | 63244084 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 95.02.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9057 / max 57.9344, expressed in 298 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 188333 | 1.5141 | 283 |
| 188334 | 0.3698 | 188 |
| 188331 | 0.0137 | 4 |
| 188332 | 0.0062 | 1 |
| 188328 | 0.0020 | 1 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| nucleus accumbens | UBERON:0001882 | 95.02 | gold quality |
| amygdala | UBERON:0001876 | 95.00 | gold quality |
| putamen | UBERON:0001874 | 93.67 | gold quality |
| hypothalamus | UBERON:0001898 | 93.31 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.13 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 91.72 | gold quality |
| substantia nigra | UBERON:0002038 | 91.62 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.33 | gold quality |
| midbrain | UBERON:0001891 | 90.57 | gold quality |
| temporal lobe | UBERON:0001871 | 89.42 | gold quality |
| Ammon’s horn | UBERON:0001954 | 88.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 88.43 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.26 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.57 | gold quality |
| ventricular zone | UBERON:0003053 | 87.17 | gold quality |
| kidney epithelium | UBERON:0004819 | 87.14 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.89 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 86.57 | gold quality |
| spinal cord | UBERON:0002240 | 86.49 | gold quality |
| ventral tegmental area | UBERON:0002691 | 86.34 | gold quality |
| sural nerve | UBERON:0015488 | 86.04 | gold quality |
| forebrain | UBERON:0001890 | 85.89 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 85.47 | gold quality |
| brain | UBERON:0000955 | 85.36 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.10 | gold quality |
| cerebral cortex | UBERON:0000956 | 85.06 | gold quality |
| neocortex | UBERON:0001950 | 84.54 | gold quality |
| metanephros cortex | UBERON:0010533 | 84.45 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.29 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 84.17 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-93593 | yes | 306.05 |
| E-GEOD-84465 | yes | 24.36 |
| E-ANND-3 | yes | 4.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting NKAIN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-3199 | 99.17 | 65.19 | 696 |
| HSA-MIR-8052 | 99.17 | 65.01 | 719 |
| HSA-MIR-4716-5P | 98.82 | 68.57 | 1168 |
| HSA-MIR-3149 | 98.77 | 67.13 | 1639 |
| HSA-MIR-7851-3P | 98.72 | 64.88 | 980 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-744-3P | 97.99 | 67.76 | 637 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-6859-3P | 97.26 | 64.69 | 428 |
| HSA-MIR-4712-5P | 97.24 | 67.79 | 775 |
| HSA-MIR-770-5P | 97.24 | 68.10 | 758 |
| HSA-MIR-6742-5P | 96.32 | 64.01 | 869 |
| HSA-MIR-541-3P | 96.07 | 66.11 | 1271 |
| HSA-MIR-654-5P | 96.07 | 66.18 | 1280 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nkain4 | ENSDARG00000062699 |
| mus_musculus | Nkain4 | ENSMUSG00000027574 |
| rattus_norvegicus | Nkain4 | ENSRNOG00000031834 |
| drosophila_melanogaster | NKAIN | FBGN0085442 |
| caenorhabditis_elegans | WBGENE00011760 |
Paralogs (3): NKAIN1 (ENSG00000084628), NKAIN3 (ENSG00000185942), NKAIN2 (ENSG00000188580)
Protein
Protein identifiers
Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 — Q8IVV8 (reviewed: Q8IVV8)
Alternative names: Protein FAM77A
All UniProt accessions (4): Q8IVV8, A6NNM2, J3JS66, J9JIE8
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with ATP1B1.
Subcellular location. Cell membrane.
Similarity. Belongs to the NKAIN family.
RefSeq proteins (3): NP_001350647, NP_001350676, NP_690603* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008516 | Na/K-Atpase_Interacting | Family |
Pfam: PF05640
UniProt features (8 total): sequence variant 4, transmembrane region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IVV8-F1 | 71.39 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 67 (showing top):
AREB6_03, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, MYOD_Q6, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, LEIN_CEREBELLUM_MARKERS, NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON, HATADA_METHYLATED_IN_LUNG_CANCER_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, CBX5_TARGET_GENES, CEBPZ_TARGET_GENES, GREB1_TARGET_GENES
GO Biological Process (1): regulation of sodium ion transport (GO:0002028)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sodium ion transport | 1 |
| regulation of metal ion transport | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
536 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NKAIN4 | ATP1B1 | P05026 | 821 |
| NKAIN4 | AMZ1 | Q400G9 | 493 |
| NKAIN4 | CMYA5 | Q8N3K9 | 493 |
| NKAIN4 | CCDC57 | Q2TAC2 | 474 |
| NKAIN4 | FASTKD3 | Q14CZ7 | 466 |
| NKAIN4 | DNAJC12 | Q9UKB3 | 459 |
| NKAIN4 | DMRT3 | Q9NQL9 | 456 |
| NKAIN4 | RDM1 | Q8NG50 | 452 |
| NKAIN4 | LRRN4 | Q8WUT4 | 447 |
| NKAIN4 | FAM111A | Q96PZ2 | 447 |
| NKAIN4 | STK31 | Q9BXU1 | 446 |
| NKAIN4 | FREM2 | Q5SZK8 | 425 |
| NKAIN4 | OR6T1 | Q8NGN1 | 418 |
| NKAIN4 | MESP2 | Q0VG99 | 418 |
| NKAIN4 | RASAL1 | O95294 | 418 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAL | NKAIN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAIN4 | ENDOD1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAL | NKAIN4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): MAL (Two-hybrid), NKAIN4 (Negative Genetic), CAV2 (Affinity Capture-MS), ENDOD1 (Affinity Capture-MS)
ESM2 similar proteins: A2VE61, A6QNL6, Q0IHU6, Q0VFK3, Q17QL9, Q17R16, Q2YDG0, Q32NX4, Q3KRC4, Q3URJ8, Q401C0, Q4KMZ8, Q4PNJ2, Q5BL21, Q5R7B1, Q5R9I4, Q5RET6, Q5U4E0, Q5VXU1, Q5ZMP3, Q61088, Q66IV3, Q66KY5, Q68EY2, Q6DD32, Q6DEX3, Q6DHB5, Q6NYY9, Q6P360, Q6PHL4, Q7TSY2, Q7Z7J7, Q810F1, Q86UP9, Q8BXA5, Q8IVV8, Q8IWA5, Q8K3J9, Q8N8D7, Q8WVP7
Diamond homologs: A6MHQ4, A6QNL6, Q0IHU6, Q0VFH9, Q32NX4, Q3URJ8, Q4KMZ8, Q4PNJ2, Q5VXU1, Q66KY5, Q66KZ9, Q6DEX3, Q6PHL4, Q8IVV8, Q8N8D7, Q9D035, Q9JMG4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1495 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:63247572:GCTCA:G | donor_loss | 1.0000 |
| 20:63247573:CTCA:C | donor_loss | 1.0000 |
| 20:63247574:TCA:T | donor_loss | 1.0000 |
| 20:63247575:CA:C | donor_loss | 1.0000 |
| 20:63247576:A:AC | donor_gain | 1.0000 |
| 20:63247577:C:CC | donor_gain | 1.0000 |
| 20:63247577:C:CT | donor_loss | 1.0000 |
| 20:63247577:CCG:C | donor_gain | 1.0000 |
| 20:63247771:CTGTC:C | acceptor_gain | 1.0000 |
| 20:63247772:TGTCC:T | acceptor_loss | 1.0000 |
| 20:63247777:T:G | acceptor_loss | 1.0000 |
| 20:63248810:CTCA:C | donor_loss | 1.0000 |
| 20:63248811:TCACC:T | donor_loss | 1.0000 |
| 20:63248812:CACCT:C | donor_loss | 1.0000 |
| 20:63248813:A:AC | donor_gain | 1.0000 |
| 20:63248813:AC:A | donor_gain | 1.0000 |
| 20:63248814:C:CC | donor_gain | 1.0000 |
| 20:63248814:C:CG | donor_loss | 1.0000 |
| 20:63248814:CC:C | donor_gain | 1.0000 |
| 20:63248891:GTGTA:G | acceptor_gain | 1.0000 |
| 20:63248892:TGTA:T | acceptor_gain | 1.0000 |
| 20:63248893:GTA:G | acceptor_gain | 1.0000 |
| 20:63248893:GTAC:G | acceptor_loss | 1.0000 |
| 20:63248894:TA:T | acceptor_gain | 1.0000 |
| 20:63248894:TAC:T | acceptor_loss | 1.0000 |
| 20:63248895:AC:A | acceptor_loss | 1.0000 |
| 20:63248896:C:CA | acceptor_loss | 1.0000 |
| 20:63248896:C:CC | acceptor_gain | 1.0000 |
| 20:63248897:T:G | acceptor_loss | 1.0000 |
| 20:63249933:ACCAC:A | donor_gain | 1.0000 |
AlphaMissense
1342 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:63248860:G:C | N76K | 0.899 |
| 20:63248860:G:T | N76K | 0.899 |
| 20:63247599:A:C | S150R | 0.884 |
| 20:63247599:A:T | S150R | 0.884 |
| 20:63247601:T:G | S150R | 0.884 |
| 20:63248865:A:G | W75R | 0.867 |
| 20:63248865:A:T | W75R | 0.867 |
| 20:63248886:A:G | W68R | 0.852 |
| 20:63248886:A:T | W68R | 0.852 |
| 20:63250040:G:C | F29L | 0.836 |
| 20:63250040:G:T | F29L | 0.836 |
| 20:63250042:A:G | F29L | 0.836 |
| 20:63242616:G:C | F180L | 0.830 |
| 20:63242616:G:T | F180L | 0.830 |
| 20:63242618:A:G | F180L | 0.830 |
| 20:63247755:G:C | F98L | 0.826 |
| 20:63247755:G:T | F98L | 0.826 |
| 20:63247757:A:G | F98L | 0.826 |
| 20:63249971:G:C | F52L | 0.824 |
| 20:63249971:G:T | F52L | 0.824 |
| 20:63249973:A:G | F52L | 0.824 |
| 20:63250025:C:A | W34C | 0.815 |
| 20:63250025:C:G | W34C | 0.815 |
| 20:63250055:C:A | R24S | 0.815 |
| 20:63250055:C:G | R24S | 0.815 |
| 20:63250007:G:C | N40K | 0.795 |
| 20:63250007:G:T | N40K | 0.795 |
| 20:63242622:A:C | F178L | 0.790 |
| 20:63242622:A:T | F178L | 0.790 |
| 20:63244024:A:G | F178L | 0.790 |
dbSNP variants (sampled 300 via entrez): RS1000103456 (20:63245842 A>G), RS1000134541 (20:63245661 C>A,T), RS1000155526 (20:63253750 C>A), RS1000180622 (20:63256541 T>G), RS1000267582 (20:63255373 G>A), RS1000313409 (20:63249201 C>T), RS1000428627 (20:63251062 G>A), RS1000492247 (20:63252703 A>C), RS1000615464 (20:63248582 T>C), RS1000686783 (20:63249399 G>A), RS1000692981 (20:63251696 T>C), RS1000764867 (20:63252371 G>A), RS1001135973 (20:63243650 GT>G), RS1001257150 (20:63245390 C>A), RS1001473942 (20:63249092 C>G,T)
Disease associations
OMIM: gene MIM:612873 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, affects cotreatment, decreases expression | 6 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| Vorinostat | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| nutlin 3 | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Methotrexate | decreases expression | 1 |
| Oxygen | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.